mba in pharmaceutical and healthcare business
in this section
mba in pharmaceutical and healthcare business
your goals, your schedule, your future—in our specialized mba program, the focus is always on all three.
we offer one of the few specialized mba programs in the country dedicated exclusively to the pharmaceutical and healthcare business, and the first mba program offering a medical cannabis business management option. three post-graduate certificate are also offered. and as part of philadelphia college of pharmacy, we are uniquely positioned to train executives for these sectors.
source: fall 2018 survey of mba alumni from 2004-2018 on behalf of usciences. more info
a specialized mba makes sense
the benefits and outcomes of a specialized mba add up. according to a survey of our mba graduates:
- 87% had a job within 6 months
- 90% make more than $75,000 and 52% make more than $125,000
- 90% had received at least one promotion, or had changed jobs for a higher one, since graduation
- 93% were in the healthcare and pharmaceutical industries
and find employment with pharmaceutical companies, biotechnology companies, consulting firms, healthcare communities, medical device manufacturers, and diagnostic providers—companies like Merck, Johnson & Johnson, GSK, Teva Pharmaceuticals, and Quintiles IMS.
source: fall 2018 survey of mba alumni from 2004-2018 on behalf of usciences. more info
source: fall 2018 survey of mba alumni from 2004-2018 on behalf of usciences. more info
on-campus evening program or online mba
we cater to your busy lifestyle with flexible options
on-campus evening mba— classes meet once a week for 15 weeks, and students can finish in as few as 22 months. seminar-style classes typically include 8 to 20 students participating in lively conversations, exchanging ideas with everyone involved.
online mba—small, private online courses promote active engagement between faculty and students. the real-time webinar format closely replicates the classroom experience. finish in 27 months following the recommended curriculum of fourteen classes delivered in 8 week modules, 4 semester long applied learning courses delivered over 15 weeks, two courses conducted as a five-day intensive learning experience and a one day on campus presentation of the capstone project.
courses cost $1,000 per credit and the you may switch seamlessly between the two formats.
post-graduate certificates
designed for individuals with advanced degrees and professional experience in the pharmaceutical and healthcare industry, our post-graduate certificate programs prepare you with industry-specific knowledge and skills to advance your career. you can earn your certificate in as few as 12 months or as long as four years.
- pharmaceutical business
- pharmaceutical marketing
- finance
what sets us apart?
- faculty from leading pharmaceutical and healthcare businesses who are executives and academic
leaders bringing real-world experience to the classroom
- small class sizes with personalized attention
- experiential learning which allows you to establish connections with industry professionals while helping
real businesses make key decisions.
- gmat and gre scores are not required to apply to the mba or certificate
prestige. our specialized mba program is ranked as tier one by ceo magazine.
accreditation
our bs in pharmaceutical and healthcare business and mba in pharmaceutical and healthcare business programs are accredited by the accreditation council for business schools and programs (acbsp), a leading specialized accreditation association for business education supporting, celebrating, and rewarding teaching excellence.
graduation and retention
for our 2012-2013 entering students the graduation rate was 70%. full time mba students can complete the degree within 22 months. the graduation rate reflects percentage of 2012-2013 mba students who graduated on or before may 2018.
the retention rate for ay 2017-2018 was 90%. retention rate refers to the total of graduates and active students retained from fall 2016 – spring 2017 to fall 2017-spring 2018.
student learning outcomes
86% of our mba students achieved good to excellent performance, as measured by the
faculty using aacu value rubrics for written and oral communication, and critical
thinking, for academic years 2017–2018 and 2018–2019. for a complete listing of student
learning outcomes including rubrics, pre and post test results and external benchmarking,
click here.
news
view all- anuja gupta named chair of department of pharmaceutical healthcare business
july 28, 2020
dr. gupta has been named chair of the department of pharmaceutical healthcare business and director of the mba program effective july 1.
- dig it: student's passion leads to month-long excavation trip in belize
june 30, 2020
victoria pobok bio'20, humsci'20 has always loved learning about ancient cultures and this summer she was able to indulge that curiosity during a month-long archeological dig in northern belize studying the ancient maya.
- in nigeria, mba student learns global impact of healthcare
november 05, 2019
ashwin mathew mba'20 was selected to participate in the six-month volunteer opportunity with the clinton health access initiative (chai) in nigeria, where he has received a fresh perspective on the challenges of improving healthcare in extremely rural settings.
- ursinus college, usciences sign affiliation agreement
june 25, 2019
ursinus grads can pursue advanced degrees in one of 12 usciences graduate programs
- usciences mba ranked in ceo mag's list of tier one programs
april 02, 2019
ceo magazine has ranked university of the sciences' mba in pharmaceutical and healthcare business among the tier one programs offering the degree.
contact:
adriane medford, mba
address:
university of the sciences
600 south 43rd street
philadelphia, pa 19104-4495
phone:
215-596-7547
email: